Treatment Options for Recurrent Non-Small Cell Lung Cancer
Treatment of recurrent
non-small cell lung cancer
- External radiation therapy
as palliative therapy, to relieve pain and other symptoms
and improve the quality of life.
with or without targeted therapy
with a monoclonal antibody, such as ramucirumab.
- Targeted therapy with a monoclonal antibody, such as nivolumab, pembrolizumab, or atezolizumab.
- Targeted therapy with a tyrosine kinase inhibitor, such as erlotinib, gefitinib, or crizotinib, for tumors
with certain gene
- Laser therapy
or internal radiation therapy
that are blocking the airways.
to remove cancer
that has spread to the brain, followed by radiation therapy
to the whole brain.
- Stereotactic radiosurgery
for tumors that have spread to the brain and cannot be treated with surgery.
Check the list of NCI-supported cancer clinical trials that are now accepting patients with recurrent non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
CancerHelp Online® is a patient education
program of The CancerHelp Institute, official Content Distribution Partner of
the National Cancer Institute.
CancerHelp Online © 2017